Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?
Yancy
Clyde W
CW
Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX, USA. clydey@baylorhealth.edu
Feldman
Arthur
A
D001741:Black or African American; D002309:Cardiology / Q000379:methods; D004338:Drug Combinations; D006333:Heart Failure / Q000188:drug therapy* / Q000208:ethnology*; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage*; D007548:Isosorbide Dinitrate / Q000008:administration & dosage*; D008962:Models, Theoretical; D011110:Polymorphism, Genetic; D057170:Translational Research, Biomedical; D016896:Treatment Outcome
D004338:Drug Combinations; D006830:Hydralazine; D007548:Isosorbide Dinitrate